VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $390,000 | -87.5% | 14,833 | -51.7% | 0.00% | -89.5% |
| Q4 2015 | $3,122,000 | +92.5% | 30,718 | +237.8% | 0.02% | +72.7% |
| Q3 2015 | $1,622,000 | -38.8% | 9,093 | -23.8% | 0.01% | -35.3% |
| Q2 2015 | $2,652,000 | +46.7% | 11,938 | +31.1% | 0.02% | +41.7% |
| Q1 2015 | $1,808,000 | +36.8% | 9,107 | -1.5% | 0.01% | +33.3% |
| Q4 2014 | $1,322,000 | +7.1% | 9,243 | -1.8% | 0.01% | 0.0% |
| Q3 2014 | $1,234,000 | +4.0% | 9,415 | -0.0% | 0.01% | +12.5% |
| Q2 2014 | $1,186,000 | – | 9,416 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |